Isabell Pink
- Infectious Diseases top 5%
- Neurology top 10%
- Molecular Biology
- Epidemiology
- Surgery
- Co-authors
- B. CreamerTobias WelteMarius M. HoeperSascha DavidJan FugeD N CroftJessica RademacherRalf‐Peter Vonberg
- Topics
- Long-Term Effects of COVID-19 (11 papers)COVID-19 Clinical Research Studies (8 papers)SARS-CoV-2 and COVID-19 Research (6 papers)
- Journals
- The LancetPLoS ONEGut
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Isabell Pink
26 papers receiving 722 citations
Peers
Comparison fields: 5 of 98
- Infectious Diseases 287
- Neurology 150
- Molecular Biology 138
- Epidemiology 123
- Surgery 109
Countries citing papers authored by Isabell Pink
This map shows the geographic impact of Isabell Pink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabell Pink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabell Pink more than expected).
Fields of papers citing papers by Isabell Pink
This network shows the impact of papers produced by Isabell Pink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabell Pink. The network helps show where Isabell Pink may publish in the future.
Co-authorship network of co-authors of Isabell Pink
This figure shows the co-authorship network connecting the top 25 collaborators of Isabell Pink. A scholar is included among the top collaborators of Isabell Pink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabell Pink. Isabell Pink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 21 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | 7 | |
| 14 | 16 | |
| 15 | 79 | |
| 16 | 110 | |
| 17 | 111 | |
| 18 | 4 | |
| 19 | 60 | |
| 20 | 37 |
About Isabell Pink
Isabell Pink is a scholar working on Neurology, Gastroenterology and Applied Microbiology and Biotechnology, having authored 29 papers that have together received 775 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (11 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Gastroenterology (102 citations), Applied Microbiology and Biotechnology (34 citations) and Infectious Diseases (287 citations). Isabell Pink has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include B. Creamer, Tobias Welte, Marius M. Hoeper, Sascha David, Jan Fuge, D N Croft, Jessica Rademacher, Ralf‐Peter Vonberg, Kai Lehmberg and Karin Beutel. Their work appears in journals such as The Lancet, PLoS ONE and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.